Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rumi Mifuji

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Metabolic Brain Disease|May 24, 2012
Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRIMotoh Iwasa, Rumi Mifuji-Moroka, Makoto Kuroda, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis CNaoki Fujita, Ryosuke Sugimoto, Masaki Takeo, et al.
Journal of Gastroenterology|November 27, 2004
Dubin-Johnson-like black liver with normal bilirubin levelYoshinao Kobayashi, Tomoaki Ishihara, Morimasa Wada, et al.
Plos One|August 13, 2013
Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosisMotoh Iwasa, Yoshinao Kobayashi, Rumi Mifuji-Moroka, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 10, 2013
Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosisMotoh Iwasa, Kazuko Iwata, Nagisa Hara, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2017
The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)Yoshinao Kobayashi, Nagisa Hara, Ryosuke Sugimoto, et al.
Metabolic Brain Disease|June 30, 2016
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2016
Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with CirrhosisNagisa Hara, Motoh Iwasa, Ryosuke Sugimoto, et al.
Journal of Gastroenterology and Hepatology|October 5, 2007
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis CNaoki Fujita, Ryosuke Sugimoto, Naohito Urawa, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjectsKeisuke Takeuchi, Yoshinao Kobayashi, Shigenori Tamaki, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Metabolic Brain Disease|May 24, 2012
Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRIMotoh Iwasa, Rumi Mifuji-Moroka, Makoto Kuroda, et al.
Molecular Medicine (Cambridge, Mass.)|May 23, 2007
Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis CNaoki Fujita, Ryosuke Sugimoto, Masaki Takeo, et al.
Journal of Gastroenterology|November 27, 2004
Dubin-Johnson-like black liver with normal bilirubin levelYoshinao Kobayashi, Tomoaki Ishihara, Morimasa Wada, et al.
Plos One|August 13, 2013
Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosisMotoh Iwasa, Yoshinao Kobayashi, Rumi Mifuji-Moroka, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|October 10, 2013
Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosisMotoh Iwasa, Kazuko Iwata, Nagisa Hara, et al.
Internal Medicine (Tokyo, Japan)|April 7, 2017
The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD)Yoshinao Kobayashi, Nagisa Hara, Ryosuke Sugimoto, et al.
Metabolic Brain Disease|June 30, 2016
Factors contributing to the development of overt encephalopathy in liver cirrhosis patientsMotoh Iwasa, Ryosuke Sugimoto, Rumi Mifuji-Moroka, et al.
Internal Medicine (Tokyo, Japan)|April 19, 2016
Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with CirrhosisNagisa Hara, Motoh Iwasa, Ryosuke Sugimoto, et al.
Journal of Gastroenterology and Hepatology|October 5, 2007
Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis CNaoki Fujita, Ryosuke Sugimoto, Naohito Urawa, et al.
Journal of Gastroenterology and Hepatology|August 12, 2004
Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjectsKeisuke Takeuchi, Yoshinao Kobayashi, Shigenori Tamaki, et al.
Pageof 3